Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Mounjaro is an injectable medication prescribed for adults with type 2 diabetes to help manage their blood sugar levels
Daniel ODay, Gileads Chairman and Chief Executive Officer, called 2023 another strong year for Gileads base business, driven by both HIV and Oncology. Total full year 2023 product sales of $26.9 billion were relatively flat compared to the same period in 2022
it's a foundational part of how we manage our health
Cost depends on your dose and plan
Some patients benefit from fragrance-free moisturizer or hydrocortisone cream applied after injection, pending provider approval
SURPASS-4, a multicenter open-label RCT comparing treatment with tirzepatide and insulin glargine in T2D patients at increased CV risk for a median of 85 weeks, was the only study in the SURPASS program to include the change from baseline in eGFR and UACR and occurrence of eGFR decline of at least 40%, renal death, progression to end-stage kidney disease or new-onset MA among the prespecified analyses [48]
